Coagulation Factor VIIa variant (Catalyst Biosciences)

N/A

Report date: 2024/04/11 14:02:18

Base Information

Drug NameCoagulation Factor VIIa variant (Catalyst Biosciences)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionFactor VIIa replacementsCoagulation factor IX stimulantsCoagulation factor X stimulants
TargetsCoagulation factor IXCoagulation factor X
Therapy Area/IndicationsThrombastheniaHemophilia AFactor VII Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkraineRussian Federation +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCatalyst Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCatalyst Biosciences Inc
Active IndicationsN/A
Inactive IndicationsThrombastheniaHemophilia AFactor VII Deficiency

Other Information

ATC CodeN/A
Related LinksN/A